RUPILIP 20MG TAB C30 IMIQUIMOD 50.00 MG FORMA FARMACÉUTICA: 18 CAPSULAS

Description

FORMA FARMACÉUTICA: 18 CAPSULAS

Tratamiento de melanoma avanzado o metastásico con mutación BRAF

especialmente en pacientes con riesgo de sangrado

FORMA FARMACÉUTICA: 1 POLVO

PRINCIPIO ACTIVO: EUCALYPTUS

RUPILIP 20MG TAB C30 IMIQUIMOD 50.00 MG FORMA FARMACÉUTICA: 18 CAPSULAS

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy